Is Cingulate Inc. (CING) a Buy, Sell, or Hold?
Cingulate Inc.
NASDAQ:CING
$4.71 USD
$0.03 (0.64%)
- Volume
- 205.28K
- Average Volume
- 567.05K
- Market Capitalization
- $26.4M
- P/E Ratio
- -0.94
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $11.89
- Year Low
- $3.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.55
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
27
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
5
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 14325
CING Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CING Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Silva Raul R. | officer: EVP and CSO | 2026-06-30 | A-Award | 5.47 | 2026-07-02 |
| Hargroves Thomas Jeffrey | director | 2026-02-13 | P-Purchase | 5.04 | 2026-06-08 |
| Hargroves Thomas Jeffrey | director | 2026-02-13 | P-Purchase | 5.04 | 2026-06-08 |
| Hargroves Thomas Jeffrey | director | 2026-03-09 | A-Award | 6.85 | 2026-06-08 |
| Hargroves Thomas Jeffrey | director | 2026-02-13 | 0 | 2026-06-08 | |
| Hargroves Thomas Jeffrey | director | 2021-12-10 | 1440 | 2026-06-08 | |
| Silva Raul R. | officer: EVP and CSO | 2026-03-31 | A-Award | 6.21 | 2026-05-08 |
| Silva Raul R. | officer: EVP and CSO | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Silva Raul R. | officer: EVP and CSO | 2026-03-09 | F-InKind | 0 | 2026-03-11 |
| Schaffer Shane J. | director, officer: Chief Executive Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Schaffer Shane J. | director, officer: Chief Executive Officer | 2026-03-09 | F-InKind | 0 | 2026-03-11 |
| Callahan Jennifer L. | officer: EVP and CFO | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Callahan Jennifer L. | officer: EVP and CFO | 2026-03-09 | F-InKind | 0 | 2026-03-11 |
| Patel Nilay Dahyabhai | officer: EVP, CLO and CCO | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Patel Nilay Dahyabhai | officer: EVP, CLO and CCO | 2026-03-09 | F-InKind | 0 | 2026-03-11 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2026-03-09 | F-InKind | 0 | 2026-03-11 |
| Werth Peter J. | director | 2026-02-06 | P-Purchase | 5.04 | 2026-02-10 |
| Werth Peter J. | director | 2026-02-06 | P-Purchase | 5.04 | 2026-02-10 |
| Callahan Jennifer L. | officer: SVP and CFO | 2026-02-06 | P-Purchase | 5.04 | 2026-02-10 |
| Callahan Jennifer L. | officer: SVP and CFO | 2026-02-06 | P-Purchase | 5.04 | 2026-02-10 |
| Schaffer Shane J. | director, officer: Chief Executive Officer | 2026-02-06 | P-Purchase | 5.04 | 2026-02-10 |
| Schaffer Shane J. | director, officer: Chief Executive Officer | 2026-02-06 | P-Purchase | 5.04 | 2026-02-10 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2026-02-06 | P-Purchase | 5.04 | 2026-02-10 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2026-02-06 | P-Purchase | 5.04 | 2026-02-10 |
| Silva Raul R. | officer: EVP and CSO | 2025-12-31 | A-Award | 4.34 | 2026-01-05 |
| Silva Raul R. | officer: EVP and CSO | 2025-09-30 | A-Award | 3.92 | 2025-11-10 |
| Downey Bryan Wade | officer: Chief Commercial Officer | 2025-11-03 | A-Award | 3.8 | 2025-11-10 |
| Downey Bryan Wade | officer | 2025-11-03 | 0 | 2025-11-10 | |
| Patel Nilay Dahyabhai | officer: CLO and CCO | 2025-07-08 | A-Award | 4.51 | 2025-07-10 |
| Patel Nilay Dahyabhai | officer | 2025-07-08 | 0 | 2025-07-10 | |
| Silva Raul R. | officer: EVP and CSO | 2025-07-07 | A-Award | 4.42 | 2025-07-09 |
| Myers Laurie | officer: EVP and COO | 2025-07-07 | A-Award | 4.42 | 2025-07-09 |
| Schaffer Shane J. | director, officer: Chief Executive Officer | 2025-07-07 | A-Award | 4.42 | 2025-07-09 |
| Callahan Jennifer L. | officer: SVP and CFO | 2025-07-07 | A-Award | 4.42 | 2025-07-09 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2025-07-07 | A-Award | 4.42 | 2025-07-09 |
| Silva Raul R. | officer: EVP and CSO | 2025-06-30 | A-Award | 4.07 | 2025-07-01 |
| Silva Raul R. | officer: EVP and CSO | 2025-03-31 | A-Award | 4.3 | 2025-07-01 |
| Ervin Jeffrey S | director | 2025-06-20 | A-Award | 4.14 | 2025-06-23 |
| ROBERTS JOHN A | director | 2025-06-20 | A-Award | 4.14 | 2025-06-23 |
| Lawrence Bryan Jay | director | 2025-06-20 | A-Award | 4.14 | 2025-06-23 |
| Werth Peter J. | director | 2025-06-20 | A-Award | 4.14 | 2025-06-23 |
| Callahan Jennifer L. | officer: SVP and CFO | 2025-02-18 | A-Award | 4.32 | 2025-02-20 |
| Myers Laurie | officer: EVP and COO | 2025-02-18 | A-Award | 4.32 | 2025-02-20 |
| Schaffer Shane J. | director, officer: Chief Executive Officer | 2025-02-18 | A-Award | 4.32 | 2025-02-20 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2025-02-18 | A-Award | 4.32 | 2025-02-20 |
| Silva Raul R. | officer: EVP and CSO | 2025-02-18 | A-Award | 4.32 | 2025-02-20 |
| Callahan Jennifer L. | officer: SVP and CFO | 2025-01-17 | A-Award | 4.76 | 2025-01-22 |
| Silva Raul R. | officer: EVP and CSO | 2025-01-17 | A-Award | 4.76 | 2025-01-22 |
| Myers Laurie | officer: EVP and COO | 2025-01-17 | A-Award | 4.76 | 2025-01-22 |
| Schaffer Shane J. | director, officer: Chief Executive Officer | 2025-01-17 | A-Award | 4.76 | 2025-01-22 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2025-01-17 | A-Award | 4.76 | 2025-01-22 |
| Silva Raul R. | officer: EVP and CSO | 2024-12-31 | A-Award | 4.93 | 2025-01-07 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2024-12-31 | A-Award | 4.93 | 2025-01-07 |
| Silva Raul R. | officer: EVP and CSO | 2024-09-30 | A-Award | 5.04 | 2024-10-01 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2024-09-30 | A-Award | 5.04 | 2024-10-01 |
| Myers Laurie | officer: EVP and COO | 2024-08-15 | S-Sale | 4.165 | 2024-08-19 |
| Silva Raul R. | officer: EVP and CSO | 2024-06-28 | A-Award | 0.32 | 2024-07-02 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2024-06-28 | A-Award | 0.32 | 2024-07-02 |
| Werth Peter J. | director, 10 percent owner: | 2024-06-12 | A-Award | 0.7 | 2024-06-13 |
| Werth Peter J. | director, 10 percent owner: | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Schaffer Shane J. | director, officer: Chief Executive Officer | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Callahan Jennifer L. | officer: SVP and CFO | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| ROBERTS JOHN A | director | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| ROBERTS JOHN A | director | 2024-06-12 | A-Award | 0.7 | 2024-06-13 |
| ROBERTS JOHN A | director | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Myers Laurie | officer: EVP and COO | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Ervin Jeffrey S | director | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Ervin Jeffrey S | director | 2024-06-12 | A-Award | 0.7 | 2024-06-13 |
| Ervin Jeffrey S | director | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Silva Raul R. | officer: EVP and CSO | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Lawrence Bryan Jay | director | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Lawrence Bryan Jay | director | 2024-06-12 | A-Award | 0.7 | 2024-06-13 |
| Lawrence Bryan Jay | director | 2024-06-11 | A-Award | 1.18 | 2024-06-13 |
| Werth Peter J. | director, 10 percent owner: | 2024-04-11 | M-Exempt | 0.0001 | 2024-04-12 |
| Werth Peter J. | director, 10 percent owner: | 2024-04-11 | M-Exempt | 0.002 | 2024-04-12 |
| Werth Peter J. | director, 10 percent owner: | 2024-04-11 | M-Exempt | 0.0001 | 2024-04-12 |
| Werth Peter J. | director, 10 percent owner: | 2024-04-11 | M-Exempt | 0.002 | 2024-04-12 |
| Silva Raul R. | officer: EVP and CSO | 2024-03-29 | A-Award | 1.1 | 2024-04-01 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2024-03-29 | A-Award | 1.1 | 2024-04-01 |
| Werth Peter J. | director, 10 percent owner: | 2024-03-25 | J-Other | 0.0001 | 2024-03-27 |
| Callahan Jennifer L. | officer: SVP and CFO | 2022-03-15 | P-Purchase | 120 | 2024-03-22 |
| Callahan Jennifer L. | officer: SVP and CFO | 2022-03-15 | P-Purchase | 27.1 | 2024-03-22 |
| Schaffer Shane J. | director, officer: Chief Executive Officer | 2024-03-04 | A-Award | 1.18 | 2024-03-06 |
| ROBERTS JOHN A | director | 2024-03-04 | A-Award | 1.18 | 2024-03-06 |
| Werth Peter J. | director | 2024-03-04 | A-Award | 1.18 | 2024-03-06 |
| Ervin Jeffrey S | director | 2024-03-04 | A-Award | 1.18 | 2024-03-06 |
| Silva Raul R. | officer: EVP and CSO | 2024-03-04 | A-Award | 1.18 | 2024-03-06 |
| Lawrence Bryan Jay | director | 2024-03-04 | A-Award | 1.18 | 2024-03-06 |
| Brams Matthew | officer: EVP and Chief Medical Officer | 2024-03-04 | A-Award | 1.18 | 2024-03-06 |
| Myers Laurie | officer: EVP and COO | 2024-03-04 | A-Award | 1.18 | 2024-03-06 |
| Callahan Jennifer L. | officer: SVP and CFO | 2024-03-04 | A-Award | 1.18 | 2024-03-06 |
| Lawrence Bryan Jay | director: | 2024-02-12 | 0 | 2024-02-14 | |
| Ervin Jeffrey S | director: | 2024-02-12 | 0 | 2024-02-14 | |
| ROBERTS JOHN A | director: | 2024-02-12 | 0 | 2024-02-14 | |
| Werth Peter J. | director, 10 percent owner: | 2024-01-25 | J-Other | 0.0001 | 2024-01-29 |
| Silva Raul R. | officer: EVP and CSO | 2023-12-29 | A-Award | 7.65 | 2024-01-02 |
| Silva Raul R. | officer: EVP and CSO | 2023-09-29 | A-Award | 0.709 | 2023-10-02 |
| Callahan Jennifer L. | officer: Corporate Controller | 2023-09-15 | P-Purchase | 0.6697 | 2023-09-18 |